<?xml version='1.0' encoding='utf-8'?>
<document id="32037158"><sentence text="Establishment of a primary human hepatocyte spheroid system for evaluating metabolic toxicity using dacarbazine under conditions of CYP1A2 induction."><entity charOffset="100-111" id="DDI-PubMed.32037158.s1.e0" text="dacarbazine" /></sentence><sentence text="Some drugs induce cytochrome P450s (CYPs), and thus may cause increased metabolic toxicity from concomitantly administered agents" /><sentence text=" Hence, we need a means of evaluating the potential of compounds to cause drug-induced liver injury (DILI) under conditions where inducers of CYP1A2 are present" /><sentence text=" Here, we present a system for evaluating CYP1A2-mediated metabolic toxicity using three-dimensional (3D) cultures of primary human hepatocyte spheroids treated with the CYP1A2 inducer omeprazole (OPZ)"><entity charOffset="185-195" id="DDI-PubMed.32037158.s4.e0" text="omeprazole" /><entity charOffset="197-200" id="DDI-PubMed.32037158.s4.e1" text="OPZ" /><pair ddi="false" e1="DDI-PubMed.32037158.s4.e0" e2="DDI-PubMed.32037158.s4.e0" /><pair ddi="false" e1="DDI-PubMed.32037158.s4.e0" e2="DDI-PubMed.32037158.s4.e1" /></sentence><sentence text=" As a test substrate, we employed dacarbazine (DTIC), which causes toxicity during the metabolic process"><entity charOffset="34-45" id="DDI-PubMed.32037158.s5.e0" text="dacarbazine" /><entity charOffset="47-51" id="DDI-PubMed.32037158.s5.e1" text="DTIC" /><pair ddi="false" e1="DDI-PubMed.32037158.s5.e0" e2="DDI-PubMed.32037158.s5.e0" /><pair ddi="false" e1="DDI-PubMed.32037158.s5.e0" e2="DDI-PubMed.32037158.s5.e1" /></sentence><sentence text=" We measured cell viability, CYP1A2 mRNA expression level and metabolism of DTIC, as well as several markers of hepatic function, i"><entity charOffset="76-79" id="DDI-PubMed.32037158.s6.e0" text="DTIC" /></sentence><sentence text="e" /><sentence text=" albumin secretion, urea secretion, and aspartate aminotransferase (AST) leakage"><entity charOffset="40-49" id="DDI-PubMed.32037158.s8.e0" text="aspartate" /></sentence><sentence text=" Markers of hepatic function were significantly decreased by addition of OPZ and DTIC even under conditions where the cell viability was largely unchanged"><entity charOffset="73-81" id="DDI-PubMed.32037158.s9.e0" text="OPZ" /><entity charOffset="81-89" id="DDI-PubMed.32037158.s9.e1" text="DTIC" /><pair ddi="false" e1="DDI-PubMed.32037158.s9.e0" e2="DDI-PubMed.32037158.s9.e0" /><pair ddi="false" e1="DDI-PubMed.32037158.s9.e0" e2="DDI-PubMed.32037158.s9.e1" /></sentence><sentence text=" This experimental system sensitively detected CYP1A2-mediated metabolic toxicity" /><sentence text=" Therefore, the developed system should be helpful for evaluating the potential of compounds to cause DILI under conditions where inducers of CYP1A2 are present" /><sentence text="" /></document>